Obesity White Papers & Case Studies

  1. Early QT/TQT Studies 8/24/2026

    Cut cardiac safety timelines and potentially waive TQT studies. Dr. Vince Clinical Research's Clario-certified Phase I unit combines 48-channel telemetry with EPQT expertise to meet ICH E14 requirements faster.

  2. Your Full Service CRO™ 8/24/2026

    Discover how specialized expertise, innovative technology, and purpose-built resources can come together to accelerate early-phase clinical research and deliver quality, efficient outcomes.

  3. Renal And Hepatic Impairment Studies 8/24/2026

    Explore how experienced teams, strategic site partnerships, and comprehensive research capabilities can help streamline complex organ impairment studies and support high-quality outcomes.

  4. Every Decision Starts With The Right Biospecimen 8/21/2026

    Learn how biospecimens, clinical data, cohort identification, and specialized laboratory services come together to support complex translational and biomarker research initiatives.

  5. Advancing IHC Assays From RUO To Clinical Trials And CDx 8/21/2026

    Examine how an exploratory IHC assay evolved into a multi-indication clinical program through integrated assay development, validation, regulatory strategy, and scientific collaboration.

  6. A Practical Guide To Harnessing The Value Of APAC For Global Trial Success 8/21/2026

    As Phase III costs and complexity rise, APAC offers faster enrollment, lower costs, and market access advantages, but capturing that value requires early planning and in-region expertise.

  7. Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations 8/20/2026

    Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.

  8. Scaling Investigational Drug Services: A Case Study in Overcoming Operational Bottlenecks 8/20/2026

    Are operational bottlenecks holding back your research site? Explore a blueprint for automating investigational product workflows and giving staff time back for patient care.

  9. Leading Rare Disease Research 8/18/2026

    Rare disease trials demand specialized expertise. Learn how patient- and site-focused strategies can reduce burden, strengthen recruitment and retention, and support trial success.

  10. Accelerating Recruitment In A Challenging Phase III Rare Disease Trial 8/18/2026

    Recruiting for rare acute diseases is challenging. Discover how this organization used rapid site activation and investigator engagement to speed enrollment in a Phase III Anti-GBM trial.